Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

1st Edition - July 14, 2015

Editors: Carrie Markgraf, Thomas Hudzik, David Compton

Language: English
Hardback ISBN:
9 7 8 - 0 - 1 2 - 4 2 0 1 7 2 - 9
eBook ISBN:
9 7 8 - 0 - 1 2 - 4 2 0 2 1 6 - 0

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice method… Read more

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote
Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug. By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.